Corvus Pharmaceuticals, Inc. CRVS
11.62
(0.18)
(1.53%)
as of 25 Sep
- Market cap
- $992.6M
- P/E
- 0.0×
Follow CRVS
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
6.21 | 1.54 | 4.07 | 4.06 | 7.36 | 3.73 | 7.76 | 16.45 | 10.17 | 22.89 |
Net Debt/EBITDA |
1.28 | 1.82 | 1.12 | 1.31 | 1.83 | 1.03 | 1.60 | 2.34 | 1.61 | 3.78 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
2.15 | 0.41 | 0.89 | 0.65 | 0.85 | 5.80 | 0.80 | 0.87 | 0.83 | 0.77 |
Capex/Depreciation |
0.14 | 0.00 | 0.05 | (1.25) | (0.01) | (0.10) | (0.25) | (1.49) | (0.41) | (1.77) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (32.60%) | (174.85%) | (57.02%) | (53.90%) | (51.08%) | (8.37%) | (51.44%) | (48.10%) | (51.15%) | (71.53%) | |
| (21.83%) | (108.85%) | (47.51%) | (46.49%) | (44.35%) | (7.09%) | (46.24%) | (44.07%) | (47.39%) | (30.49%) | |
ROIC |
(602.85%) | 0.00% | (126.83%) | (147.36%) | (87.13%) | (98.07%) | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(31.16%) | (325.19%) | (126.76%) | (124.18%) | (69.66%) | (17.58%) | (66.13%) | (42.39%) | (65.53%) | (27.28%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.42) | (0.42) | (0.50) | (0.59) | (0.88) | (1.18) | (1.27) | (1.50) | (2.27) | (1.95) |
Cash per Share |
0.72 | 0.85 | 0.57 | 0.91 | 1.66 | 1.50 | 2.66 | 4.17 | 4.40 | 8.75 |
Shareholders Equity per Share |
0.78 | 0.53 | 0.81 | 1.21 | 2.32 | 2.45 | 2.42 | 4.01 | 4.14 | 8.61 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.78 | 0.53 | 0.81 | 1.21 | 2.32 | 2.45 | 2.42 | 4.01 | 4.14 | 8.61 |
Free Cash Flow |
(32.97) | (25.42) | (23.97) | (27.27) | (36.72) | (34.85) | (37.35) | (41.34) | (46.48) | (30.06) |
Working Capital |
48.83 | 19.01 | 21.09 | 32.91 | 61.62 | 33.19 | 69.12 | 108.56 | 82.27 | 130.09 |
Capital Expenditures |
(0.17) | 0.01 | (0.03) | (0.25) | 0.00 | (0.08) | (0.02) | (0.35) | (0.27) | (2.20) |
Net Current Asset Value |
48.30 | 18.07 | 21.09 | 31.54 | 59.02 | 31.96 | 66.81 | 107.69 | 81.29 | 128.68 |
| Other line items | ||||||||||
Quick Ratio |
6.05 | 1.47 | 3.96 | 3.99 | 7.22 | 3.65 | 7.66 | 16.36 | 10.06 | 22.76 |
Depreciation/Fixed assets |
(5.64) | (6.99) | (3.15) | 0.56 | 1.55 | 0.87 | 0.07 | 0.11 | 0.24 | 0.38 |
Cash ROIC |
(27.99%) | (30.25%) | (36.72%) | (27.82%) | (22.31%) | (30.65%) | (26.01%) | (19.19%) | (27.95%) | (11.62%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.42) | (0.42) | (0.50) | (0.58) | (0.88) | (1.18) | (1.27) | (1.49) | (2.26) | (1.81) |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | 0.00 | 0.00 | 0.00 | (0.01) | (0.01) | (0.14) |
Average Receivables |
0.06 | 0.05 | 0.31 | 0.55 | 0.30 | 0.21 | 0.33 | 0.23 | 0.25 | 0.25 |
Average Payables |
2.54 | 2.05 | 1.75 | 1.77 | 2.52 | 2.96 | 2.22 | 2.73 | 2.68 | 1.74 |
Average Assets |
70.01 | 57.23 | 56.90 | 88.85 | 97.49 | 84.59 | 100.94 | 106.50 | 117.46 | 119.30 |
Average Common Equity |
46.89 | 35.63 | 47.40 | 76.64 | 84.66 | 71.63 | 90.72 | 97.59 | 108.82 | 50.85 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates